Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses

Amid controversial reports that COVID-19 can be treated with a combination of the antimalarial drug hydroxychloroquine (HCQ) and the antibiotic azithromycin (AZI), a clinical trial (ONCOCOVID, NCT04341207) was launched at Gustave Roussy Cancer Campus to investigate the utility of this combination th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Liu, Peng, Zhao, Liwei, Ferrere, Gladys, Alves-Costa-Silva, Carolina, Ly, Pierre, Wu, Qi, Tian, Ai-Ling, Derosa, Lisa, Zitvogel, Laurence, Kepp, Oliver, Kroemer, Guido
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458592/
https://ncbi.nlm.nih.gov/pubmed/32923151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1789284
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados